A Study to Asses the Effect of MK0663 in the Treatment of Patients With Postoperative Dental Pain (0663-092)

• Status: Completed
• Trial end date: 2009-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the pain relieving effect of different doses of MK0663 with placebo and other pain relievers/analgesics in patients with postoperative dental pain. Pain intensity and relief will be measured by the total pain relief score (TOPAR) and patient evaluation.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Acetaminophen; Codeine; Etoricoxib; Ibuprofen

Criteria

Inclusion Criteria:

• Patients must be scheduled to have 2 or more third molars removed, at least 1 of which is partially embedded in bone and is impacted in the lower jaw

• Patients must be experiencing moderate to severe pain following the dental procedure

Exclusion Criteria:

• Previous molar extraction within the past 45 days

• Personal or family history of an inherited bleeding disorder

• Uncontrolled high blood pressure